 A: PATIENT
45: PATIENT
year: PATIENT
old: PATIENT
female: PATIENT
with: 
history: 
of: 
sickle: 
cell: 
disease: BEFORE
presented: BEFORE
with: 
abdominal: 
pain: BEFORE
.: 
A: 
CT: 
scan: BEFORE
revealed: BEFORE
an: 
exophytic: 
renal: 
mass: BEFORE
measuring: BEFORE
2.9cm: RML
x: RML
2.0cm: RML
x: RML
2.1cm: RML
located: 
on: 
the: 
antero-lateral: 
aspect: 
of: 
her: Body_part
right: Body_part
kidney: Body_part
and: 
an: Body_part
unremarkable: Body_part
spleen: Body_part
.: 
She: PATIENT
was: 
evaluated: BEFORE
by: 
urology: 
and: 
a: 
right: 
partial: 
nephrectomy: BEFORE
was: 
planned: BEFORE
,: 
however: 
on: 
the: DATE
day: DATE
of: 
the: 
procedure: BEFORE
,: 
the: 
patient's: PATIENT
preoperative: PREPOSTEXP
pregnancy: 
test: BEFORE
was: 
positive: RML
.: 
The: 
procedure: BEFORE
was: 
post: 
postponed: BEFORE
until: 
after: 
she: PATIENT
delivered: BEFORE
and: 
interval: 
ultrasounds: BEFORE
were: 
obtained: 
throughout: 
her: 
pregnancy: BEFORE
to: 
monitor: BEFORE
the: 
renal: 
mass: BEFORE
.: 
The: 
lesion: BEFORE
increased: BEFORE
minimally: 
in: 
size: 
.: 
Two: DURATION
months: DURATION
after: 
caesarian: 
section: 
delivery: BEFORE
,: 
patient: PATIENT
underwent: 
an: 
unremarkable: 
right: 
laparoscopic: 
partial: 
nephrectomy: BEFORE
with: 
individual: 
artery: Body_part
and: 
vein: Body_part
vascular: 
occlusion: 
at: 
the: 
level: 
of: 
the: Body_part
renal: Body_part
hilum: Body_part
.: 
A: 
superficial: 
liver: Body_part
laceration: BEFORE
caused: BEFORE
by: 
the: 
Veress: 
needle: 
was: 
noted: BEFORE
at: 
the: 
beginning: BEFORE
of: 
the: 
procedure: BEFORE
and: 
effectively: 
managed: BEFORE
using: 
bipolar: 
cautery: BEFORE
.: 
The: 
patient's: PATIENT
post-operative: PREPOSTEXP
course: BEFORE
was: 
notable: BEFORE
for: 
marked: 
thrombocytosis: BEFORE
with: 
her: 
platelet: Body_part
count: BEFORE
increasing: BEFORE
for: 
her: 
baseline: 
of: 
300,000: RML
to: 
a: 
zenith: 
of: 
1.3: RML
million: RML
.: 
She: PATIENT
was: 
started: BEFORE
on: 
aspirin: 
therapy: BEFORE
and: 
splenomegaly: BEFORE
was: 
noted: BEFORE
on: 
abdomen: Body_part
ultrasound: BEFORE
.: 
Her: 
platelet: Body_part
count: BEFORE
normalized: BEFORE
to: 
334,000: RML
.: 
On: 
pathology: BEFORE
,: 
the: 
renal: 
mass: BEFORE
was: 
classified: BEFORE
as: 
a: 
papillary: 
renal: 
neoplasm: BEFORE
consistent: 
with: 
a: 
translocation: 
carcinoma: BEFORE
.: 
There: 
was: 
no: 
splenic: Body_part
tissue: Body_part
in: 
the: 
specimen: 
.: 
It: 
was: 
noted: BEFORE
that: 
the: 
complete: 
lack: 
of: 
staining: BEFORE
of: 
any: 
keratins: 
or: 
epithelial: Body_part
membrane: Body_part
antigens: 
was: 
not: 
consistent: BEFORE
with: 
a: 
usual: 
renal: 
cell: 
carcinoma: BEFORE
and: 
hence: 
the: 
diagnosis: 
of: 
a: 
translocation: 
tumor: BEFORE
was: 
made: 
.: 
The: PATIENT
patient: PATIENT
was: 
lost: BEFORE
to: 
follow: BEFORE
up: 
presenting: CONTAINS
2: DATE
years: DATE
later: DATE
and: 
a: 
follow-up: 
CT: 
scan: IS-CONTAINED
noted: IS-CONTAINED
marked: 
splenic: 
atrophy: CONTAINS
with: 
several: 
splenules: 
.: 
The: PATIENT
patient: PATIENT
was: 
completely: 
asymptomatic: CONTAINS
and: 
at: 
the: 
time: 
received: IS-CONTAINED
all: 
the: 
post-splenectomy: PREPOSTEXP
vaccination: IS-CONTAINED
and: 
her: 
platelet: Body_part
count: CONTAINS
remained: 
within: 
normal: 
limits: CONTAINS
